I would agree with Dr. Perry, first off, that we have to be specific about what we're talking about. There are a lot of different areas where we have IP leak.
There's a fundamental layer where technology that's developed in fundamental science never goes to a tech transfer office. It never becomes commercialized, so those ideas just go out into the world. To some extent, we want to support open science where it's appropriate, but I think we want to have some more controls and make sure that we channel these into the right avenues so that we can benefit as much as possible and reuse IP as much as possible in Canada.
Then, when we're talking about IP that is commercialized and then goes out into the market, I think we lose it in a number of different ways, including companies being bought up at small stages because they don't have capital to grow and stay in Canada. That's a partnership issue, and it's a capital issue.
Again, I agree with Dr. Perry about the aversion to risk. I think not only embracing risk but also trying to de-risk certain elements that don't need to be high risk would be important for that. A more comprehensive approach to IP retention, in general, is extremely important.